Search Results - Shengnan Du
- Showing 1 - 3 results of 3
-
1
Pediatric model‐based dose optimization using a pooled exposure-response safety analysis for nivolumab and nivolumab plus ipilimumab combination in melanoma by Shengnan Du, Yue Zhao, Zheyi Hu, Sihang Liu, Amit Roy, Jun Shen, Li Zhu, Lora Hamuro
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations-Going beyond the body‐size effect by Zheyi Hu, Sihang Liu, Yue Zhao, Shengnan Du, Lora Hamuro, Jun Shen, Amit Roy, Li Zhu
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Targeted degradation of LRG1 to attenuate renal fibrosis by Linyao Fan, Yingqiu Qi, Xi Yang, Yarui Xu, Yana Zhang, Longdi Wang, Anying Zhu, Lirong Zhang, Jian Song, Shengnan Du, Guangjun Nie, Huan Min
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book